CompletedNCT00029614
Atomoxetine for teens with ADHD and alcohol or substance use
About this title
Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD
Read the official source — NCT00029614Medication studyAges 13–18United StatesAddiction
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 13 years to 18 years. Other eligibility criteria applied.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMay 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 13 Years to 18 Years
- Official registry ID
- NCT00029614
- Official title
Show the full official title
Psychopharmacology of Adolescents With AUD and ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine.
Who was this study for?
This study was for people with ADHD. Listed age limits: 13 years to 18 years. Other eligibility criteria applied.
